ABBV-RGX-314

INCHEON, South Korea, July 20, 2026 Samsung Biologics has announced a landmark all-cash public tender offer to acquire 100%...

REDMOND, Wash., July 17, 2026 SystImmune Inc. announced that its parent company, Sichuan Biokin Pharmaceutical Co., Ltd., has received...

ROCKVILLE, Md., July 18, 2026 REGENXBIO Inc. has announced positive long-term clinical data for its investigational one-time gene therapy,...

ROCKVILLE, Md., June 29, 2026 REGENXBIO Inc. has reached a major milestone in the advancement of gene therapy for...